OVERVIEW

The 57th Annual Neurology Update and Stroke Intensive Review 2024 provides clinicians with a comprehensive review of the most recent developments in the diagnosis and management of neurologic disorders, including stroke, cognitive neurology/brain health, epilepsy, multiple sclerosis (MS), movement disorders, neuromuscular disorders, headache/migraine, neuropsychology, sleep disorders and general neurology.

Challenging diagnostic and therapeutic questions will be raised in each session around representative clinical vignettes, targeted reviews of the topic by the faculty and panel discussions. Exchange of information between faculty and attendees will take place during questions and answers sessions after each presentation as well as round table and panel discussions.

In addition, a dedicated stroke seminar will take place Saturday, designed as a stand-alone 8-hour CME activity.  For those centers planning to seek stroke center status or already designated as a stroke center, this course will provide stroke teams with the most up-to-date evidence in the field of stroke diagnosis, treatment and prevention. 

LEARNING OBJECTIVES

At the conclusion of this activity, learners will be able to:

1. Cognitive Disorders: Describe the many different presentations and pathologies associated with dementia and how they can potentially detect them
2. Multiple Sclerosis: Recognize the benefit of obtaining NFL levels to diagnose and manage Multiple Sclerosis
3. Sleep Disorders: Evaluate recent literature and ongoing research regarding the link between sleep disorders and neurological disease and treatment options including surgical treatment for sleep apnea
4. Epilepsy: Distinguish autoimmune epilepsy from epileptic seizures that result from an autoimmune encephalitis and plan the proper treatment
5. Epilepsy: Recognize the autoimmune cause of status epilepticus
6. Headache/Migraine: Identify patients who could benefit from migraine preventive therapies to formulate, initiate, and reinforce a patient-centered migraine prevention plan, with focus on the update for recent pharmacologic and non-pharmacologic strategies
7. Headache/Migraine: Explore the diagnosis and treatment paradigms for various headache disorders, including less common and refractory migraine types
8. Movement Disorders: Delineate the complexities and challenges presented by advanced Parkinson’s Disease therapies, emphasizing their potential side effects and the scenarios in which they are most likely to arise
9. Movement Disorders: Impart strategies and guidelines for identifying and managing side effects early, optimizing patient outcomes and ensuring safety
10. Movement Disorders: Outline the primary challenges of accurate identification and categorization of ataxia amidst its wide range of presentations
11. Multiple Sclerosis: Identify usefulness and availability of NeuroQuant services and the community and applications in clinical practice
12. Multiple Sclerosis: Analyze clinical trial data on efficacy of Bruton tyrosine kinase (BTK) inhibitors in the management of MS
13. Neuromuscular Disorders: Summarize the recent identification of autoantibodies associated with inflammatory neuropathies and review their correlation with clinical presentation and treatment response
14. Neuromuscular Disorders: Review the recent completed clinical trials for ALS
15. Neuromuscular Disorders: Outline an approach to the diagnosis of myositis based on autoantibody profiling
16. Stroke: Treat appropriate acute ischemic stroke patients with modern strategies that include the extended 24-hour treatment window with thrombolytics, endovascular approaches and antithrombotic
17. Stroke: Establish appropriate management of intracerebral hemorrhage according to current guidelines for the management of hypertensive and lobar hemorrhages as well as the role of reversal strategies in coagulopathic hemorrhages.
18. Stroke: Institute measures to prevent a recurrent stroke based on stroke mechanism and in special populations according to the most recent guidelines and evidence
19. Sleep Disorders: Evaluate recent literature and ongoing research regarding the link between sleep disorders and neurological disease and treatment options including surgical treatment for sleep apnea
20. Neuropsychological Dislorders: Examine the factors that contribute to neurocognitive concerns following mild traumatic brain injury and the potential appropriate interventions

TARGET AUDIENCE

The course is aimed primarily at neurologists, stroke specialists, neurosurgeons, psychiatrists, neuro-oncologists, hospitalists, intensivists, fellows, residents, nurses and allied healthcare professionals that participate in the care of neurological patients or work in stroke centers.  Internists, general practitioners and cardiologists may also find the topics timely and useful.

Specialties - Alzheimer's/Cognitive Disorders, Epilepsy, General Neurology, Headache/Migraine, Movement Disorders, Multiple Sclerosis, Neurology, Neuromuscular Diseases, Neuro-Oncology, Neuropsychology, Neurosurgery, Sleep Medicine, Stroke
Professions - Allied Health Professional, Exhibitor, Fellow, Medical Student, Non-Physician, Nurse, Nurse Practitioner, Other, Pharmacist, Physician, Physician Assistant, Psychologist, Research, Resident, Scientist

ACCREDITATION

The University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation:

The University of Miami Leonard M. Miller School of Medicine designates this Live Activity for a maximum of 23.00 of AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.